Astringents are substances that:
Forced alkaline diuresis is useful in the poisoning of which substance?
What are orphan drugs?
When one drug decreases or inhibits the action of another, what is it called?
Which of the following statements about immunosuppressants is INCORRECT?
A child has phocomelia. This is due to a drug taken by the mother. Which drug is most likely responsible?
All of the following are examples of mechanism-based inhibition, EXCEPT?
Local anaesthetics act by inhibiting which of the following?
Which of the following best describes the ionization state of a drug when the pH of the environment equals the drug's pKa?
Which of the following is NOT a side effect of prostaglandins?
Explanation: **Explanation:** **Astringents** are locally applied pharmacotherapeutic agents that act by **precipitating surface proteins** (Option B). When applied to skin or mucous membranes, they react with tissue proteins to form a protective layer of protein precipitate. This process results in the contraction of tissues, constriction of small blood vessels, and a reduction in secretions. **Analysis of Options:** * **Option A (Irritate sensory nerve endings):** This describes **Counter-irritants** (e.g., Capsaicin). Astringents, conversely, tend to decrease surface sensitivity by forming a protective barrier over nerve endings. * **Option C (Penetrate target cell nucleus):** This is the mechanism of action for **Steroid hormones** or **Thyroid hormones**. Astringents have low penetrability and act purely on the surface; they do not enter the cell or nucleus. * **Option D (Reduce inflammation):** While astringents may have a mild secondary anti-inflammatory effect by reducing exudation, they are not classified as anti-inflammatory drugs. Their primary, defining pharmacological action is protein precipitation. **High-Yield Clinical Pearls for NEET-PG:** * **Common Examples:** * **Vegetable/Organic:** Tannic acid (Tannins). * **Mineral/Inorganic:** Alum (Aluminum potassium sulfate), Zinc sulfate, and Ferric chloride. * **Clinical Uses:** * To stop minor bleeding (haemostatic/styptic action). * To reduce secretions in conditions like diarrhea (Tannic acid). * To treat weeping skin lesions (Zinc sulfate) and promote healing of ulcers. * **Key Distinction:** Unlike **Corrosives**, astringents precipitate proteins only on the surface and do not cause deep tissue destruction.
Explanation: Explanation: Concept: Ion Trapping The principle behind forced alkaline diuresis (FAD) is ion trapping. Most drugs are weak acids or weak bases. According to the Henderson-Hasselbalch principle, an acidic drug exists in a non-ionized (lipid-soluble) form in an acidic medium and an ionized (water-soluble) form in an alkaline medium. By alkalinizing the urine (using IV Sodium Bicarbonate), weak acids like Barbiturates (specifically Phenobarbital) and Salicylates become ionized. Once ionized, they cannot be reabsorbed by the renal tubules and are rapidly excreted. Analysis of Options: Barbiturates (Correct): Phenobarbital is a long-acting acidic drug. Alkalinizing the urine to a pH of 7.5–8.5 significantly increases its clearance. Lead (Incorrect): Lead is a heavy metal. Treatment requires chelating agents like Calcium disodium EDTA, Succimer, or Penicillamine. Morphine (Incorrect): Morphine is a weak base. Alkalinization would actually increase its reabsorption. Furthermore, the primary treatment for morphine overdose is the specific opioid antagonist, Naloxone. Iron (Incorrect): Iron poisoning is managed with the specific chelator Deferoxamine. FAD has no role in removing elemental metals. High-Yield Clinical Pearls for NEET-PG: Forced Alkaline Diuresis is primarily used for: Salicylates (Aspirin) and Phenobarbital. Forced Acidic Diuresis (using Ammonium Chloride) was historically used for weak bases like Amphetamines or Quinine but is no longer recommended clinically due to the risk of precipitating metabolic acidosis and acute renal failure (myoglobinuria). Prerequisite for FAD: Ensure the patient has adequate renal function and monitor for hypokalemia, as alkalinization promotes K+ entry into cells.
Explanation: **Explanation:** **Orphan drugs** are pharmaceutical agents specifically developed to diagnose, prevent, or treat **rare diseases** (conditions affecting a small percentage of the population). In India, a disease is generally considered rare if it affects fewer than 1 in 2,500 people, while in the US, it is defined as affecting fewer than 200,000 people. **Why Option B is correct:** The term "orphan" is used because these drugs lack commercial viability under normal market conditions. Because the patient population is so small, the cost of research, development, and marketing would outweigh the potential financial returns. To encourage pharmaceutical companies to develop these life-saving treatments, governments provide incentives like tax credits, clinical research subsidies, and extended patent exclusivity (e.g., the Orphan Drug Act). **Why other options are incorrect:** * **Option A:** Orphan drugs are often **difficult to obtain** and extremely expensive due to limited production and specialized distribution. * **Option C:** These drugs are developed despite a **lack of monetary gain**. They are "orphaned" by the industry because they are not profitable without government intervention. **High-Yield Clinical Pearls for NEET-PG:** * **Examples of Orphan Drugs:** Digoxin Immune Fab (for digitalis toxicity), Fomepizole (for methanol poisoning), Thalidomide (for leprosy/multiple myeloma), and Sodium Nitrite (for cyanide poisoning). * **Conditions:** Rare diseases include Huntington’s disease, Cystic Fibrosis, and various "inborn errors of metabolism." * **Regulatory Fact:** The US FDA provides **7 years** of market exclusivity for orphan drugs to compensate for the small market size.
Explanation: **Explanation:** **1. Why Antagonism is correct:** **Antagonism** is defined as the phenomenon where one drug opposes, decreases, or inhibits the action of another drug or an endogenous ligand. This can occur through various mechanisms: * **Receptor Antagonism:** Binding to the same receptor (e.g., Atropine blocking Acetylcholine). * **Physical/Chemical Antagonism:** Direct interaction between drugs (e.g., Charcoal adsorbing toxins). * **Physiological Antagonism:** Two drugs acting on different receptors to produce opposite effects (e.g., Glucagon and Insulin on blood sugar). **2. Why other options are incorrect:** * **Agonism:** Refers to a drug that binds to a receptor and activates it to produce a maximal biological response (e.g., Adrenaline at $\beta_1$ receptors). * **Inverse Agonism:** A drug that binds to the same receptor as an agonist but produces an effect **opposite** to that of the agonist. This occurs only in receptors with "constitutive activity" (e.g., Beta-carbolines at GABA receptors). * **Synergism:** The opposite of antagonism; it occurs when the combined effect of two drugs is greater than the sum of their individual effects ($1+1=3$) or when one drug enhances the effect of another (Potentiation). **3. NEET-PG Clinical Pearls:** * **Competitive Antagonism:** Shifts the Dose-Response Curve (DRC) to the **right** (increases $EC_{50}$), but the maximal response ($E_{max}$) remains unchanged. It can be overcome by increasing the agonist concentration. * **Non-competitive Antagonism:** Flattens the DRC, reducing the **$E_{max}$** because the antagonist binds irreversibly or to an allosteric site. * **High-Yield Example:** Naloxone is a competitive antagonist used in Opioid overdose.
Explanation: ### Explanation **1. Why Option C is the Correct (Incorrect Statement):** Mycophenolate mofetil (MMF) inhibits **Inosine Monophosphate Dehydrogenase (IMPDH)**, not GMP dehydrogenase. This is a crucial distinction in the de novo pathway of purine synthesis. By inhibiting IMPDH, MMF prevents the conversion of Inosine Monophosphate (IMP) to Guanosine Monophosphate (GMP). Since T and B lymphocytes rely almost exclusively on the de novo pathway (rather than the salvage pathway), MMF effectively suppresses their proliferation. **2. Analysis of Incorrect Options (Correct Statements):** * **Option A:** Tacrolimus (and Cyclosporine) are **calcineurin inhibitors**. They bind to FK-binding protein (FKBP-12), forming a complex that inhibits calcineurin, thereby preventing the dephosphorylation of NFAT and the subsequent transcription of IL-2. * **Option B:** Glucocorticoids are lipophilic and cross the cell membrane to bind to **cytosolic receptors**. In their inactive state, these receptors are bound to **heat shock proteins (HSP90)**. Binding causes the release of HSPs, allowing the receptor-steroid complex to translocate to the nucleus. * **Option C:** Sirolimus (Rapamycin) binds to FKBP-12, but unlike tacrolimus, it inhibits the **mTOR (mammalian Target of Rapamycin)** kinase. This blocks the signal transduction downstream of the IL-2 receptor, arresting the cell cycle in the G1-S phase. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice:** Mycophenolate is preferred over Azathioprine in renal transplants due to better efficacy and less bone marrow toxicity. * **Side Effects:** Tacrolimus is more associated with **nephrotoxicity and post-transplant diabetes**, while Sirolimus is notorious for **hyperlipidemia and impaired wound healing**. * **Mnemonic:** **S**irolimus = **S**tops the **S**ignal (IL-2 response); **C**yclosporine/Tacrolimus = **C**ut the **C**ommunication (IL-2 production).
Explanation: **Explanation:** The correct answer is **Thalidomide**. This question tests the concept of **Teratogenicity**, specifically the "Thalidomide Disaster" of the late 1950s. **1. Why Thalidomide is correct:** Thalidomide was originally used as an anti-emetic for morning sickness. However, it is a potent teratogen that interferes with angiogenesis (vessel formation) in the developing limb buds. This leads to **Phocomelia**, a condition characterized by "seal-like limbs" where the long bones are absent or grossly underdeveloped, and hands/feet are attached directly to the trunk. The critical period of exposure is between the **24th and 36th day** of gestation. **2. Why the other options are incorrect:** * **Tetracycline:** Causes permanent **yellow-brown discoloration of teeth** and enamel hypoplasia, as well as inhibition of bone growth. * **Warfarin:** Leads to **Fetal Warfarin Syndrome**, characterized by nasal hypoplasia, depressed nasal bridge, and stippled epiphyses (chondrodysplasia punctata). * **Chloroquine:** Generally considered safe in pregnancy for malaria, but high doses are associated with **ototoxicity** (8th cranial nerve damage) and retinal damage in the fetus. **3. NEET-PG High-Yield Pearls:** * **Current uses of Thalidomide:** Despite its history, it is now used for **Multiple Myeloma** and **Erythema Nodosum Leprosum (ENL)** due to its anti-TNFα and anti-angiogenic properties. * **S-Isomer:** The teratogenicity is specifically linked to the S-enantiomer of the drug. * **Other limb defects:** Do not confuse Phocomelia with **Sirenomelia** (mermaid syndrome), which is associated with maternal diabetes.
Explanation: ### Explanation **Mechanism-based inhibition**, also known as **suicide inhibition** or irreversible covalent inhibition, occurs when an enzyme converts an initially inactive inhibitor (a "prodrug" or substrate analog) into a reactive intermediate. This intermediate then binds covalently and irreversibly to the enzyme's active site, permanently "killing" the enzyme. **Why Statins are the Correct Answer:** Statins (e.g., Atorvastatin) are **competitive, reversible inhibitors** of HMG-CoA reductase. They structurally resemble the natural substrate (HMG-CoA) and compete for the same binding site. Because the binding is non-covalent and reversible, they do not qualify as suicide inhibitors. **Analysis of Incorrect Options (Suicide Inhibitors):** * **Aspirin:** It irreversibly acetylates the serine residue at the active site of **Cyclooxygenase (COX-1 and COX-2)**. This is a classic example of covalent modification. * **Allopurinol:** It is converted by **Xanthine Oxidase** into its active metabolite, **Alloxanthine (Oxypurinol)**. Alloxanthine then binds tightly and irreversibly to the molybdenum ion in the enzyme's active site. * **Difluoromethylornithine (DFMO/Eflornithine):** It is a substrate analog that is activated by **Ornithine Decarboxylase**, leading to irreversible enzyme inactivation. It is used clinically for African Trypanosomiasis and hirsutism. **High-Yield NEET-PG Pearls:** * **Other Suicide Inhibitors:** Clavulanic acid (on $\beta$-lactamase), Selegiline (on MAO-B), Disulfiram (on Aldehyde dehydrogenase), and 5-Fluorouracil (on Thymidylate synthase). * **Key Distinction:** In competitive inhibition (Statins), $V_{max}$ remains unchanged while $K_m$ increases. In suicide inhibition, the enzyme is permanently inactivated, effectively decreasing the total enzyme concentration ($V_{max}$ decreases).
Explanation: **Explanation:** **Mechanism of Action:** Local anesthetics (LAs) act by blocking the **voltage-gated sodium channels** from the inner surface of the neuronal membrane. When a nerve is stimulated, sodium channels open to allow an **influx of sodium ions**, which causes depolarization and the generation of an action potential. LAs bind to the specific receptors within the sodium channel pore, preventing this influx. By inhibiting sodium entry, LAs prevent depolarization, thereby blocking nerve impulse conduction. **Analysis of Options:** * **Option C (Correct):** LAs specifically target the "activated" and "inactivated" states of sodium channels to prevent the **influx** of Na+ ions into the cell. * **Option A & B:** While sodium is a cation, these options are too vague. The specific mechanism is tied to the sodium ion species rather than general cation movement. * **Option D:** Efflux of sodium ions is mediated by the Na+/K+ ATPase pump to restore resting potential; LAs do not primarily act on this process to achieve anesthesia. **High-Yield NEET-PG Pearls:** * **State-Dependent Block:** LAs have a higher affinity for channels in the **open (activated)** and **inactivated** states rather than the resting state. This is why rapidly firing nerves are blocked faster (Use-dependent block). * **pH Dependency:** LAs are weak bases. In **acidic environments** (e.g., infected tissues/abscesses), LAs become ionized and cannot cross the lipid membrane, leading to reduced efficacy. * **Order of Blockade:** Small myelinated fibers > Small unmyelinated fibers > Large myelinated fibers. * **Sensitivity:** Pain > Temperature > Touch > Deep Pressure > Motor function.
Explanation: ### Explanation The ionization state of a drug is governed by the **Henderson-Hasselbalch Equation**, which describes the relationship between the pH of the medium, the pKa of the drug, and the ratio of its ionized to unionized forms. **Why Option A is Correct:** The Henderson-Hasselbalch equation is expressed as: * **For Weak Acids:** $pH = pKa + \log \frac{[Ionized]}{[Unionized]}$ * **For Weak Bases:** $pH = pKa + \log \frac{[Unionized]}{[Ionized]}$ When the **pH equals the pKa**, the value of $\log \frac{[Ionized]}{[Unionized]}$ (or vice versa) becomes **zero**. Since $\log(1) = 0$, the ratio of ionized to unionized drug must be **1:1**. Therefore, exactly **50%** of the drug exists in the ionized form and **50%** in the unionized form. **Why Other Options are Incorrect:** * **Options B & C:** These ratios occur when there is a difference between pH and pKa. For instance, a 1-unit difference in pH results in a 10:1 ratio (approx. 90% vs 10%), and a 2-unit difference results in a 100:1 ratio (approx. 99% vs 1%). * **Option D:** A drug is never "completely" ionized in biological systems, though it may approach 99.9% if the pH-pKa gradient is very high. **High-Yield Clinical Pearls for NEET-PG:** 1. **Lipid Solubility:** Only the **unionized** form of a drug is lipid-soluble and can cross biological membranes (e.g., Blood-Brain Barrier, GI tract). 2. **Ion Trapping:** This principle is used in toxicology. To treat **Aspirin (weak acid)** poisoning, we **alkalinize the urine** (using Sodium Bicarbonate). This increases the ionized fraction of the drug in the renal tubules, preventing reabsorption and enhancing excretion. 3. **Memory Aid:** "Like is unionized in like." (Acidic drugs are unionized in acidic pH; Basic drugs are unionized in basic pH).
Explanation: **Explanation:** Prostaglandins (PGs) are lipid compounds derived from arachidonic acid that act as local mediators. Their side-effect profile is directly linked to their physiological actions on smooth muscle and the central nervous system. **Why "Convulsion" is the Correct Answer:** Prostaglandins, particularly PGE2 and PGF2α, do not typically cause convulsions. In fact, some prostaglandins (like PGE1) have been studied for potential neuroprotective or anticonvulsant properties in specific contexts. Convulsions are not a recognized or common adverse effect of therapeutic prostaglandin analogues (like Misoprostol, Dinoprostone, or Carboprost). **Analysis of Incorrect Options:** * **Vomiting & Diarrhea:** These are the most common side effects of prostaglandins. PGs (especially PGF2α and PGE2) increase gastrointestinal motility and stimulate smooth muscle contraction in the gut, leading to nausea, vomiting, and watery diarrhea. * **Fever:** PGE2 acts on the thermoregulatory center in the anterior hypothalamus to increase the body’s "set-point," leading to pyrexia. This is why fever is a frequent side effect during the clinical use of prostaglandins for labor induction or abortion. **NEET-PG High-Yield Pearls:** 1. **Drug of Choice (DOC):** Misoprostol (PGE1) is the DOC for preventing NSAID-induced peptic ulcers. 2. **Obstetrics:** Carboprost (PGF2α) is used in Postpartum Hemorrhage (PPH) but is contraindicated in asthmatics due to bronchoconstriction. 3. **Ophthalmology:** Latanoprost (PGF2α) is used in glaucoma; its unique side effect is increased pigmentation of the iris and eyelashes. 4. **Cardiology:** Alprostadil (PGE1) is used to keep the Ductus Arteriosus patent in cyanotic heart diseases.
Pharmacokinetics: Absorption and Distribution
Practice Questions
Pharmacokinetics: Metabolism and Excretion
Practice Questions
Pharmacodynamics and Receptor Theory
Practice Questions
Drug-Receptor Interactions and Dose-Response
Practice Questions
Pharmacogenetics and Personalized Medicine
Practice Questions
Adverse Drug Reactions and Toxicity
Practice Questions
Drug Interactions
Practice Questions
Drug Development and Regulation
Practice Questions
Pediatric and Geriatric Pharmacology
Practice Questions
Placental Transfer and Lactation
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free